Holen Sie sich die Stockscreener-App
1.20
1.69%
0.02
Handel nachbörslich:
1.20
Schlusskurs vom Vortag:
$1.18
Offen:
$1.3
24-Stunden-Volumen:
4.05M
Relative Volume:
6.89
Marktkapitalisierung:
$44.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.94M
KGV:
-0.8696
EPS:
-1.38
Netto-Cashflow:
$-15.79M
1W Leistung:
+21.33%
1M Leistung:
-3.23%
6M Leistung:
-32.96%
1J Leistung:
-45.70%
1-Tages-Spanne:
$1.12
$1.46
1-Wochen-Bereich:
$0.95
$1.46
52-Wochen-Spanne:
$0.87
$2.74
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Firmenname
MAIA Biotechnology Inc
Sektor
Branche
Telefon
312 416 8592
Adresse
444 West Lake Street, Suite 1700, Chicago
Vergleichen Sie MAIA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.20 | 43.70M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.60 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.11 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.56 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
894.90 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
211.41 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - GlobeNewswire
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 By Investing.com - Investing.com India
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares By Investing.com - Investing.com India
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares - Investing.com
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares By Investing.com - Investing.com India
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 - Investing.com
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares - Investing.com
MAIA Biotechnology Inc Stock Analysis and ForecastMACD Histogram Signals & Affordable Market Trading - earlytimes.in
CEO’s Bold Move: Major Stock Purchase at MAIA Biotechnology! - TipRanks
Luput Cristian, director at Maia Biotechnology, buys $9,785 in shares By Investing.com - Investing.com Australia
Maia Biotech CEO Vitoc Vlad buys $10k in company stock - Investing.com India
Luput Cristian, director at Maia Biotechnology, buys $9,785 in shares - Investing.com
Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks
MAIA Biotechnology highlights momentum of ateganosine clinical program - MSN
MAIA Biotechnology CEO presents at Smart Diaspora 2025 - MSN
MAIA Biotechnology Highlights Ateganosine Progress at SITC 2025 - TipRanks
MAIA Biotechnology Highlights Ateganosine Clinical Program at SITC 2025 - TradingView
[8-K] MAIA Biotechnology, Inc. Reports Material Event | MAIA SEC FilingForm 8-K - Stock Titan
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025 - 富途牛牛
MAIA Biotechnology (MAIA) Expands Phase 2 Lung Cancer Trial and Opens Phase 3 Study - Stock Titan
MAIA Biotechnology Expands Phase 2 Study in Romania - TipRanks
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation - The Manila Times
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Conference - TradingView
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy - GlobeNewswire
Will MAIA Biotechnology Inc. stock rise with strong economyPortfolio Return Summary & Detailed Earnings Play Alerts - newser.com
MAIA Biotechnology (NYSE American: MAIA) Reports 38% Response in THIO-101 NSCLC Study in Romania - Stock Titan
Can MAIA Biotechnology Inc. stock survive global slowdownJuly 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Real time breakdown of MAIA Biotechnology Inc. stock performanceQuarterly Portfolio Report & High Accuracy Trade Signal Alerts - newser.com
Will MAIA Biotechnology Inc. stock see PE expansionWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
What MACD and RSI say about MAIA Biotechnology Inc.July 2025 Outlook & Safe Capital Preservation Plans - newser.com
Is MAIA Biotechnology Inc. stock positioned for digital transformation2025 Major Catalysts & Smart Money Movement Alerts - newser.com
Will MAIA Biotechnology Inc. stock recover after recent dropWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Why global investors buy MAIA Biotechnology Inc. stockMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
How to use a screener to detect MAIA Biotechnology Inc. breakoutsTrade Performance Summary & Verified Momentum Stock Alerts - newser.com
What momentum shifts mean for MAIA Biotechnology Inc.July 2025 Summary & Weekly Stock Performance Updates - newser.com
Historical volatility pattern of MAIA Biotechnology Inc. visualizedJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - newser.com
Is MAIA Biotechnology Inc. stock bottoming outPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Applying sector rotation models to MAIA Biotechnology Inc.Market Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
Is MAIA Biotechnology Inc. stock among top earnings plays2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.30%
1.75%
Kapitalisierung:
|
Volumen (24h):